{"lastClose": 1.100000023841858, "len": 480, "date": "2023-02-13", "alpha_1": -0.9111068776935647, "beta_1": 0.19212356500341982, "drawup_1": 0.7325581218050006, "natr_1": 33.192981930304896, "sup_1": -0.5066666348775236, "res_1": 0.010303005804372363, "bullPattern_1": [], "bearPattern_1": ["LONGLINE"], "rsi_1": 60.752685828931675, "adx_1": 50.0038513339239, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.9188934392757493, "stratHoldAlpha_1": 249.67515200677116, "stratHoldDrawdown_1": -0.815934067100103, "alpha_3mo": -0.6449914377194655, "beta_3mo": -0.3894427921516619, "drawup_3mo": 0.4117647223819081, "natr_3mo": 33.192981930304896, "sup_3mo": -0.05454550971669479, "res_3mo": 0.03181809659831965, "bullPattern_3mo": [], "bearPattern_3mo": ["HIGHWAVE", "SPINNINGTOP"], "rsi_3mo": 67.8642632881996, "adx_3mo": 77.48253930550615, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.33350962681719687, "stratHoldAlpha_3mo": 251.23308030105835, "stratHoldDrawdown_3mo": -0.3969675966724687, "Country": "Cayman Islands", "Sector": "Health Care", "Market Cap": 288077598, "Name": "LumiraDx Limited", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "alpha%_1": 0.0037314275115123132, "beta%_1": 0.06235334578764397, "drawup%_1": 0.6967640300114235, "natr%_1": 1.0, "drawdown%_1": 0.004017328932870144, "stratHoldSharpe%_1": 0.0017980910233374395, "stratHoldAlpha%_1": 2.885460051841294e-08, "stratHoldDrawdown%_1": 0.0050008257610820485, "alpha%_3mo": 0.09000697654843909, "beta%_3mo": 0.009115072751457747, "drawup%_3mo": 0.8252279852657711, "natr%_3mo": 1.0, "drawdown%_3mo": 0.0003238783456991826, "stratHoldSharpe%_3mo": 0.31752269177102116, "stratHoldAlpha%_3mo": 0.44108934018031776, "stratHoldDrawdown%_3mo": 0.00021381039747491885}